How to Buy Ovid Therapeutics Stock
Ovid Therapeutics Inc
Ovid Therapeutics Inc. , a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States.
Ovid Therapeutics stock last closed at $3.07, up 0.33% from the previous day, and has decreased 14.72% in one year. It has overperformed other stocks in the Biotechnology industry by 0.04 percentage points. Ovid Therapeutics stock is currently +19.46% from its 52-week low of $2.57, and -25.83% from its 52-week high of $4.14.
There are currently 70.71M OVID shares outstanding. The market cap of OVID is $217.08M. In the past 24 hours, 67,110 OVID shares were traded.
How to Buy Ovid Therapeutics Stock
Not sure how to invest in Ovid Therapeutics stock? Here's how.
- Figure out where to buy Ovid Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Ovid Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Choose your method of payment and add your information.
- Research Ovid Therapeutics stock: The Ovid Therapeutics ticker symbol is OVID. Is Ovid Therapeutics stock a good investment? Should you buy shares of OVID? How do OVID's underlying business fundamentals look? Do top analysts think Ovid Therapeutics is a good buy? Why has OVID's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if OVID is a good stock to buy).
- Place your OVID purchase: Decide if you will purchase OVID shares at the current market price or use a limit order to purchase OVID stock at a specific price.
- Get the latest scoop on your OVID investment: Create a watchlist to watch your position in Ovid Therapeutics stock.
Step 1: Figure out where to buy Ovid Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy OVID shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Real Estate, New York to London — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, you need to fill out some personal information so you are able to invest in OVID stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new trading account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have finished signing up on a mobile trading app, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring funds into your new investment account.
Step 4: Research Ovid Therapeutics stock
After you have chosen the best place to buy Ovid Therapeutics stock, it's important to research their stock before you invest, so you can understand the risk as well as the opportunity.
Ovid Therapeutics stock at a glance
Ovid Therapeutics Due Diligence Checks
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on OVID's stock page.
Is OVID stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge OVID's true value.
Using relative valuations measures:
- OVID could be undervalued based on its P/B ratio of 2.47x, relative to Biotechnology industry P/B ratio of 5.99x
You can do more valuation research on OVID's stock here.
How do OVID Financials look?
Signs that OVID is financially healthy:
- There are more short-term assets than short-term liabilities on the OVID balance sheet.
- OVID has $107.76M in cash and short term investments. This is sufficient to cover its annual cash burn of $45.82M.
- OVID has cash burn of 45821233. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the OVID balance sheet.
Signs that OVID is not financially healthy:
- OVID profit margin has gone down from -3,604.7% to -13,362.2% in the past year.
- OVID has a relatively high debt to equity ratio of 0.64.
- Total OVID debt is higher than 5 years ago, relative to shareholder equity.
Is OVID stock a Buy, Hold, or Sell, according to analysts?
Out of 4 sell side analysts who research OVID, the consensus analyst rating on Ovid Therapeutics is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Ovid Therapeutics stock forecast page.
OVID Momentum
OVID Performance Metrics
Last year, OVID revenue was $391.70k. Over the last three year, OVID's revenue has increased by -98.95% per year. This was slower than the Biotechnology industry average of 29.57%.
Learn more about OVID's earnings and revenue performance here.
Are OVID executives and large shareholders buying or selling the stock?
In the last year, insiders at OVID have bought more shares than they have sold.
Jeremy M. Levin, CEO of OVID, was the latest OVID insider to buy. They bought $50,364.48 worth of OVID shares on Mar 18, 2024.
Dig into more about who owns OVID stock here.
Can I rely on OVID as an income stream?
No, Ovid Therapeutics doesn't provide an income stream by paying out dividends.
OVID Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your OVID purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open Trade button and your broker will execute the order.
If you want more info about buying stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your OVID investment
Now that you own some OVID stock, you'll want to stay up-to-date on your new investment.
Make a watchlist to monitor your OVID stock.
OVID Feed
How to Buy Stock in Ovid Therapeutics
To reiterate, here are the 6 steps to buy Ovid Therapeutics stock:
- Figure out where to buy Ovid Therapeutics stock
- Sign up for your brokerage account
- Put funds into your investment account
- Research Ovid Therapeutics stock
- Place your OVID purchase
- Get the latest scoop on your OVID investment
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Ovid Therapeutics, click below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.